Itolizumab 调节效应细胞上的激活性和抑制性信号,增强其对 CD318+肿瘤细胞系的细胞毒性
Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines.
肿瘤细胞治疗研究
FRONTIER PAPERS
近 5 年肿瘤细胞治疗领域的研究论文。默认按评分排序(权威性 + 新鲜度)。
Itolizumab regulates activating and inhibitory signals on effector cells, improving their cytotoxicity against CD318+ tumor cell lines.
共 1 条
MEMBER ACCOUNT
登录成功会直接打开下一页。